Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study

2019 ◽  
Vol 145 (9) ◽  
pp. 2365-2373 ◽  
Author(s):  
Alessandro Parisi ◽  
Alessio Cortellini ◽  
Michela Roberto ◽  
Olga Venditti ◽  
Daniele Santini ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Body Mass Index ◽  
Weight Loss ◽  
Multicentre Study ◽  
Advanced Gastric Cancer ◽  
Cancer Patients ◽  
Body Mass ◽  
Real Life ◽  
Second Line ◽  
Gastric Cancer Patients

scholarly journals Prognostic Roles of Perioperative Body Mass Index and Weight Loss in the Long-Term Survival of Gastric Cancer Patients

2018 ◽  
Vol 27 (8) ◽  
pp. 955-962 ◽  
Author(s):  
Young Suk Park ◽  
Do Joong Park ◽  
Yoontaek Lee ◽  
Ki Bum Park ◽  
Sa-Hong Min ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Body Mass Index ◽  
Weight Loss ◽  
Cancer Patients ◽  
Body Mass ◽  
Term Survival ◽  
Long Term Survival ◽  
Gastric Cancer Patients

scholarly journals Efficacy of Acupuncture and Moxibustion as a Subsequent Treatment after Second-Line Chemotherapy in Advanced Gastric Cancer

2020 ◽  
Vol 2020 ◽  
pp. 1-9
Author(s):  
Yong-jie Zhang ◽  
Qi Min ◽  
Ying Huang ◽  
Huai-dong Liu ◽  
Zi-yuan Zhu ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Cancer Patients ◽  
Plasma Levels ◽  
Mrna Levels ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Acupuncture And Moxibustion ◽  
Gastric Cancer Patients ◽  
Line Chemotherapy

Objective. To explore whether acupuncture and moxibustion can prevent disease progression of advanced gastric cancer patients completing second-line chemotherapy and, if so, the related mechanism. Method. Progression-free survival (PFS) and overall survival (OS) were main outcome measures. The real-time quantitative PCR was used to detect the expression of genes including T-bet, IFN-γ, GATA3, and IL-4 in peripheral blood mononuclear cells (PBMCs). IL-4, IL-6, Ca199, CRP, and IFN-γ in plasma levels were checked. Results. 170 patients were randomly assigned in a 3 : 2 ratio to receive either acupuncture and moxibustion or sham acupuncture until progression. 135 patients were included in the primary analysis. Both PFS and OS in treatment group were proven to be better than control group. Acupuncture and moxibustion promoted typical Th1 cells drifting, as confirmed by increased T-bet/IFN-γ and decreased GATA3/IL-4 in mRNA levels from PBMCs, as well as upregulating IFN-γ and downregulating IL-4 in plasma levels. IL-6, Ca199, and CRP in plasma levels were also reduced by acupuncture and moxibustion. Conclusions. Acupuncture and moxibustion can prolong PFS and OS of advanced gastric cancer patients completing second-line chemotherapy by reversing Th1/Th2 shift and attenuating inflammatory responses.

Prognostic factors in 868 advanced gastric cancer patients exposed to second-line therapy.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e15553-e15553
Author(s):  
Valentina Fanotto ◽  
Caterina Fontanella ◽  
Mario Uccello ◽  
Giulia Pasquini ◽  
Silvia Bozzarelli ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Prognostic Factors ◽  
Advanced Gastric Cancer ◽  
Cancer Patients ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Gastric Cancer Patients

2357 Prognostic factors in 709 advanced gastric cancer patients exposed to second-line therapy

2015 ◽  
Vol 51 ◽  
pp. S454-S455
Author(s):  
C. Fontanella ◽  
V. Fanotto ◽  
M. Uccello ◽  
E. Vasile ◽  
S. Bozzarelli ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Prognostic Factors ◽  
Advanced Gastric Cancer ◽  
Cancer Patients ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Gastric Cancer Patients

Body Mass Index Does Not Affect Systematic D2 Lymph Node Dissection and Postoperative Morbidity in Gastric Cancer Patients

2003 ◽  
Vol 10 (4) ◽  
pp. 363-368 ◽  
Author(s):  
Stephan Gretschel ◽  
Frank Christoph ◽  
Andreas Bembenek ◽  
Lope Estevez-Schwarz ◽  
Ulrike Schneider ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Body Mass Index ◽  
Lymph Node ◽  
Cancer Patients ◽  
Body Mass ◽  
Lymph Node Dissection ◽  
Postoperative Morbidity ◽  
Node Dissection ◽  
D2 Lymph Node Dissection ◽  
Gastric Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document